亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Immunogenicity risk assessment of peptide-related impurities identified in generic teriparatide products

免疫原性 特立帕肽 药品 药理学 表位 风险评估 生物等效性 医学 免疫系统 计算生物学 外周血单个核细胞 抗原 人类使用 免疫学 抗体 化学 剩余风险 食品药品监督管理局 中止 活性成分 临床试验
作者
Aimee E. Mattei,Brian Roberts,Sandra Lélias,Shah Miah,Kristina E. Howard,James L. Weaver,Daniela I. Verthelyi,Eric S. Pang,Katie J. Edwards,Anne Searls De Groot
出处
期刊:Frontiers in Immunology [Frontiers Media]
卷期号:16: 1730346-1730346 被引量:3
标识
DOI:10.3389/fimmu.2025.1730346
摘要

Teriparatide is one of several generic peptides named in a recent Food and Drug Administration (FDA) guidance (FDA-2017-D-5767-0002), which outlines a potential strategy to inform immunogenicity risk assessment for synthetic generic peptides without requiring clinical studies. Specifically, the guidance states that for abbreviated new drug applications (ANDAs), once the sameness of the active pharmaceutical ingredient (API) between the generic product and the reference listed drug is established, developers can mitigate the residual risk of unwanted immunogenicity response by using in silico and in vitro tools to characterize differences in product- and process-related impurities between the reference and generic drug products. Regarding product-related impurities, a stated concern is that sequence modifications may create new T-cell epitopes capable of driving unwanted immune responses. Specifically, the guidance sets limits for the relative abundance of each impurity and requests that any new impurity above a certain concentration threshold be evaluated for potential T-cell-driven immunogenicity using orthogonal methods that assess both human leukocyte antigen (HLA) binding and the capacity to elicit a T-cell response. One such orthogonal immunogenicity risk assessment approach was applied to teriparatide (TPT) and several theoretical or observed product-related impurities in the case study described here. First, the immunogenic potential of TPT and selected impurities was assessed using three in silico tools: EpiMatrix, ClustiMer, and JanusMatrix. Second, an in vitro method was used to evaluate the binding affinity of TPT and the selected TPT impurities to different class II HLA-DRs in vitro . Third, a human peripheral blood mononuclear cell (PBMC) T-cell assay compared T-cell proliferation in response to individual impurities or the reference teriparatide drug product, Forteo ® , in vitro . The orthogonal approaches identified multiple impurities as more immunogenic than TPT. In a novel finding, the in silico analysis revealed a potentially tolerogenic sequence in TPT, which correlated with lower-than-expected de novo immune responses to TPT in vitro . The analysis and methods described in this case study may help assess the relative risk of impurities and help identify those with the potential to increase the immunogenicity risk of a generic peptide.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
半序完成签到 ,获得积分10
1秒前
2秒前
4秒前
yehata发布了新的文献求助10
4秒前
yanzilin完成签到 ,获得积分10
6秒前
lusaner完成签到 ,获得积分10
7秒前
Re发布了新的文献求助10
7秒前
8秒前
YueLongZ完成签到,获得积分10
8秒前
luyiyi发布了新的文献求助10
9秒前
9秒前
10秒前
12秒前
611完成签到,获得积分20
12秒前
健壮的鑫鹏完成签到,获得积分10
12秒前
13秒前
云雀完成签到,获得积分10
16秒前
研友_VZG7GZ的应助被monair采纳,获得10
17秒前
21度多云发布了新的文献求助10
17秒前
17秒前
23秒前
葡萄味的果茶完成签到 ,获得积分10
23秒前
jxzou完成签到,获得积分10
24秒前
初见秋风完成签到,获得积分10
24秒前
可爱的函函的应助被611采纳,获得10
26秒前
冷傲的醉山完成签到,获得积分10
26秒前
28秒前
蓝天上的流云完成签到,获得积分10
32秒前
perfect完成签到 ,获得积分10
34秒前
儒雅的白曼完成签到,获得积分10
35秒前
36秒前
可耐的花生完成签到,获得积分10
37秒前
烟花的应助被犹豫的昊焱采纳,获得20
41秒前
42秒前
yehata发布了新的文献求助10
46秒前
han完成签到,获得积分10
46秒前
49秒前
慕青的应助被yehata采纳,获得10
51秒前
CC完成签到 ,获得积分10
52秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194990
求助须知:如何正确求助?哪些是违规求助? 9580729
关于积分的说明 21872527
捐赠科研通 7794694
什么是DOI,文献DOI怎么找? 3437819
关于科研通互助平台的介绍 2561149
邀请新用户注册赠送积分活动 2484526